HspBP1 is a dual function regulatory protein that controls both DNA repair and apoptosis in breast cancer cells

Cha Kyung Youn1,2, Jung-Hee Lee1,3, Gurusamy Hariharasudhan1

  • 1DNA Damage Response Network Center, Chosun University School of Medicine, 375 Seosuk-dong, Gwangju, Republic of Korea.

Cell Death & Disease
|April 7, 2022
PubMed

Insights

Hsp70-binding protein 1 (HspBP1) suppresses breast cancer by regulating BRCA1 and DNA repair. Decreased HspBP1 in advanced cancers promotes genomic instability and radiation resistance.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Hsp70-binding protein 1 (HspBP1) is a co-chaperone regulating Hsp70, with poorly understood biological roles.
  • Breast cancer progression and treatment resistance are complex processes involving genetic instability and DNA repair mechanisms.

Purpose of the Study:

  • To investigate the role of HspBP1 in breast cancer tumorigenesis and its relationship with BRCA1.
  • To elucidate the mechanisms by which HspBP1 influences tumor suppression and response to ionizing radiation.

Main Methods:

  • Gene knockdown and overexpression in BRCA1-proficient and deficient breast cancer cell lines.
  • In vitro assays for anchorage-independent cell growth.
  • Xenograft models for in vivo tumor formation assessment.
  • Analysis of HspBP1 interactions with BRCA1 and DNA repair pathways.
  • Investigation of HspBP1's effect on Hsp70 and apoptosis-related proteins.

Main Results:

  • HspBP1 modulation significantly altered tumorigenesis in BRCA1-proficient cells but not in BRCA1-deficient cells.
  • HspBP1 interacts with BRCA1, promoting homologous recombination DNA repair and maintaining genomic stability.
  • HspBP1 enhances cell survival following ionizing radiation by interfering with Hsp70-apoptotic protease-activating factor-1 complex formation, independent of BRCA1 status.

Conclusions:

  • HspBP1 acts as a tumor suppressor in breast cancer, particularly in BRCA1-proficient contexts, by enhancing DNA repair and genomic stability.
  • Reduced HspBP1 expression, observed in high-grade and metastatic breast cancers, contributes to genomic instability and resistance to ionizing radiation therapy.
  • HspBP1 represents a potential therapeutic target for improving breast cancer treatment outcomes.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.4K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K